Focus on Adoptive T Cell Transfer Trials in Melanoma

Adoptive Cell Transfer (ACT) of Tumor-Infiltrating Lymphocytes (TIL) in combination with lymphodepletion has proven to be an effective treatment for metastatic melanoma patients, with an objective response rate in 50%–70% of the patients. It is based on the ex vivo expansion and activation of tumor-...

Full description

Saved in:
Bibliographic Details
Main Authors: Hershkovitz, Liat, Schachter, Jacob, Treves, Avraham J., Besser, Michal J.
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2010
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018069/
https://ncbi.nlm.nih.gov/pubmed/21234353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/260267
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items